Monopar Therapeutics — Director's Dealing 2018

Sep 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Monopar Therapeutics (NONE)
CIK: 0001645469
Period of Report: 2018-08-09

Reporting Person: STARR CHRISTOPHER M (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-09	Stock options	$6	A	26100	Acquired	2028-08-08	Common stock (26100)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	49400	Indirect

Footnotes

F1: 49,400 shares of Monopar Common Stock held by the Christopher M. Starr and Sheri L. Starr Revocable Trust over which Dr. Starr serves as Trustee.

F2: Stock options vest 20% on January 1, 2019, 20% on April 1, 2019, 20% on July 1, 2019, 20% on October 1, 2019 and 20% on January 1, 2020.